1. Cummings, JL and Benson, DF.(1983) Dementia: A clinical approach. Boston : Butterworths.
2. Hori, M and Iemura, R and Hideaki, H and Takayuki, S and Keizo, I and Ohtaka, H. (1991) Potential nootropic agents, 4-alkoxy-2- (1-piperazinyl) quinazoline derivatives Chem. Pharm. Bull., 39, pp. 367 - 371.
3. Giurgea, C and Salama, M. (1977) Nootropic drugs Prog. Neuro-Psychopharmacol., 1, pp. 235 - 247.
4. Piplani, P and Jindal, DP and Malik, R. (2004) 2-Naphthloxy derivative of N,N-substituted acetamides: Synthesis and pharmacological evaluation Indian J. Pharm. Sci., 66, pp. 653 - 658.
5. Crapper, DR and Dalton, AJ. (1973) Alterations in short term retention, conditioned avoidance response acquisition and motivation following aluminium induced neurofibrillary degeneration Physiol. Behav., 10, pp. 925 - 933.